Scholarlink

<p>The progression of prostate cancer (PCa) is commonly associated with the establishment of an immunosuppressive tumor microenvironment that enables immune evasion. Here, we identify ribosomal protein S4 Y-linked 1 (<i>RPS4Y1</i>) as a candidate regulator of both tumor progression and immune modulation in PCa. <i>RPS4Y1</i> is highly expressed in PCa tissues, and its downregulation significantly inhibits cancer cell proliferation, migration, and invasion. Transcriptomic profiling revealed a gene expression signature associated with immune responses following <i>RPS4Y1</i> downregulation. This signature was recapitulated in the TCGA PCa cohort. Immune response scores were significantly higher in low <i>RPS4Y1</i> expression tumors than in the high expression group. To examine the immune cell subpopulations associated with <i>RPS4Y1</i> downregulation, we analyzed public single-cell RNA sequencing (scRNA-seq) datasets, which revealed reduced tumor cell abundance and increased cytotoxic immune cell populations in the <i>RPS4Y1</i>-low group. Notably, NK cells were markedly expanded, driven by the CD56bright IL7R⁺ subset. Therefore, our study highlights the dual role of <i>RPS4Y1</i> in tumor progression and immune modulation, suggesting its potential as a therapeutic target for reprogramming the immune microenvironment in PCa.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

RPS4Y1 in immune modulation and progression of prostate cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年8月1日

查看全文
  • Fu-Lu Dong,
  • Dong-Mei Liu,
  • Pei-Da Feng,
  • Han-xin Diao,
  • Sheng Wu,
  • Jian Wang

摘要

The progression of prostate cancer (PCa) is commonly associated with the establishment of an immunosuppressive tumor microenvironment that enables immune evasion. Here, we identify ribosomal protein S4 Y-linked 1 (RPS4Y1) as a candidate regulator of both tumor progression and immune modulation in PCa. RPS4Y1 is highly expressed in PCa tissues, and its downregulation significantly inhibits cancer cell proliferation, migration, and invasion. Transcriptomic profiling revealed a gene expression signature associated with immune responses following RPS4Y1 downregulation. This signature was recapitulated in the TCGA PCa cohort. Immune response scores were significantly higher in low RPS4Y1 expression tumors than in the high expression group. To examine the immune cell subpopulations associated with RPS4Y1 downregulation, we analyzed public single-cell RNA sequencing (scRNA-seq) datasets, which revealed reduced tumor cell abundance and increased cytotoxic immune cell populations in the RPS4Y1-low group. Notably, NK cells were markedly expanded, driven by the CD56bright IL7R⁺ subset. Therefore, our study highlights the dual role of RPS4Y1 in tumor progression and immune modulation, suggesting its potential as a therapeutic target for reprogramming the immune microenvironment in PCa.